PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL TO SUPPORT OPHTHALMIC SUSPENSIONS DEVELOPMENT.

被引：0
|
作者：
Le Merdy, M. [1 ]
Fan, J. [1 ]
Babiskin, A. H. [1 ]
Zhao, L. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PBPK-011
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Lyndsey F. Meyer
    Pooja M. Rajadhyaksha
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2022, 49 : 325 - 336
  • [42] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [43] Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs
    Methaneethorn, Janthima
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Poomsaidorn, Chomkanang
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 487 - 494
  • [44] Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs
    Janthima Methaneethorn
    Kanyamas Naosang
    Parichart Kaewworasut
    Chomkanang Poomsaidorn
    Manupat Lohitnavy
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 487 - 494
  • [45] Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia
    Lee, Joomi
    Kim, Min-Gul
    Jeong, Hyeon-Cheol
    Shin, Kwang-Hee
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (01) : 33 - 44
  • [46] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [47] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATE ESTERS
    GEARHART, JM
    JEPSON, GW
    CLEWELL, HJ
    ANDERSEN, ME
    CONOLLY, RB
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 51 - 60
  • [48] Development of Physiologically-Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in human body
    Gospavic, R.
    Knoll, P.
    Mirzaei, S.
    Popov, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S342 - S342
  • [49] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ABSORPTION OF ORAL PARACETAMOL IN MAN
    CLEMENTS, JA
    NIMMO, WS
    HEADING, RC
    PRESCOTT, LF
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 : P60 - P60
  • [50] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Meyer, Lyndsey F.
    Rajadhyaksha, Pooja M.
    Shah, Dhaval K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2022, 49 (03) : 325 - 336
12345